Rare diseases
Investigational molecules
Locations
Study of Nucresiran in Adults with Transthyretin Amyloidosis with Cardiomyopathy to Evaluate its Effects on Survival and Heart Problems
SpainStudy of cemiplimab treatment after surgery in patients with stage II-IIIA non-small cell lung cancer who have not received chemotherapy and have PD-L1 expression of 1% or higher
SpainLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
SpainStudy comparing daratumumab, lenalidomide and dexamethasone followed by linvoseltamab versus continued initial treatment in newly diagnosed multiple myeloma patients
SpainStudy of BMS-986504 for patients with advanced or metastatic non-small cell lung cancer with homozygous MTAP deletion who have previously received treatment
SpainStudy of RSV vaccine immune response persistence and revaccination safety in adult lung and kidney transplant recipients
SpainStudy of ficerafusp alfa and pembrolizumab as first treatment for patients with PD-L1-positive recurrent or metastatic head and neck cancer
SpainStudy of ONO-4578 and nivolumab with drug combination for first-line treatment in patients with PD-L1 positive advanced colorectal cancer
SpainStudy of MK-5684 compared to standard therapy in patients with breast cancer, ovarian cancer, or endometrial cancer
SpainTreatment with trastuzumab deruxtecan, capecitabine and bevacizumab for patients with HER2-positive metastatic colorectal cancer
SpainStudy of felzartamab compared to placebo in adults with IgA nephropathy
SpainStudy of UGN-104 (mitomycin) treatment for patients with low-grade upper tract urothelial cancer
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
